US cellulose ether prices edged up 1.00% during the week of June 26, 2026, as constrained Chinese export supply reduced prompt import availability and provided the primary upward price impetus. Steady downstream demand from pharmaceutical tablet coating and construction chemical sectors — particularly HPMC consumption in tile adhesives and dry-mix mortars — supported the modest gain. Domestic production at facilities operated by key producers including Dow and Ashland ran at stable rates, but insufficient to fully offset tighter import flows. Near-term prices are expected to remain firm while Chinese export availability stays restricted.
US cellulose ether prices edged higher by 1.00% during the week of June 26, 2026, in a modest but meaningful upward move driven by tightening import availability from Chinese origins, steady downstream demand from pharmaceutical and construction sectors, and the partial insulation of the US market from the broader global commodity softness that characterized much of the chemical complex during the same period.
The primary driver behind the cellulose ether week's price firmness was constrained export supply from China, the world's dominant cellulose ether producer, accounting for the majority of global HPMC and HEC output. Chinese producers, managing their own domestic demand priorities and supply chain logistics, kept export volumes to the US measured during the week, reducing the inflow of competitively priced Asian-origin material that has historically been a key reference point for US spot pricing. Cellulose ether's exposure to feedstock economics is concentrated in the propylene oxide input channel, as propylene oxide is a critical reactant in producing HPMC and hydroxypropyl cellulose grades serving pharmaceutical, food, and construction applications. With propylene oxide costs softening in line with the broader crude oil price decline triggered by the US-Iran peace agreement and anticipated Strait of Hormuz reopening, the production cost floor eased modestly. However, this was more than offset by the tighter near-term availability of imported material.
On the demand side, pharmaceutical-grade cellulose ether procurement — primarily HPMC for tablet coating and controlled-release formulations — continued at steady rates, providing a resilient demand floor that is relatively inelastic to short-term commodity price swings. Over 44% of domestic pharmaceutical companies integrate cellulose ether into oral solid doses, making pharmaceutical demand a consistently supportive factor in the US market regardless of broader economic conditions. Construction sector demand from tile adhesive, dry-mix mortar, and specialty coatings applications remained active, with renovation and infrastructure project activity sustaining HPMC offtake from formulators in the US Gulf Coast and Southeast markets.
In North America, cellulose ether pricing was influenced by consistent demand from construction, coatings, and pharmaceutical sectors, with supply constrained due to reduced import volumes from Asia, leading to tighter inventories for distributors. Domestic production of cellulose ether from key US producers including Dow Chemical and Ashland ran at broadly stable operating rates, providing adequate but not surplus coverage of immediate market requirements.
Looking ahead, the near-term outlook for US cellulose ether prices is forecasted to remain modestly firm, supported by the combination of constrained Chinese import availability, steady pharmaceutical procurement, and active construction sector demand. Any meaningful price correction would likely require a significant resumption of Chinese export volumes or a notable softening in downstream demand from the construction sector, neither of which appears imminent. Market participants will continue to monitor Chinese production and export scheduling as the primary variable shaping the US cellulose ether pricing environment in the coming weeks.
